Literature DB >> 17623497

Significance of Streptococcus milleri in acute rhinosinusitis with complications.

N M Rankhethoa1, C A J Prescott.   

Abstract

OBJECTIVES: To assess the significance of Streptococcus milleri in acute rhinosinusitis with complications.
METHODS: A retrospective case note review was undertaken of in-patients at both the Red Cross Children's Hopital and the Groote Schuur Hospital (for adults), Cape Town, South Africa, between 1999 and 2003, with a diagnosis of acute rhinosinusitis with complications. The following were documented: age, gender, complications, organisms cultured and their sensitivity, type and number of operations, and length of hospital stay.
RESULTS: Seventy-one case notes were reviewed, for 30 female and 41 male patients, representing 38 adults and 33 children. Streptococcus milleri was the most commonly implicated organism (52.1 per cent; 37/71). Patients from whom this organism was isolated tended to require more than one operative procedure, and had a protracted hospital stay.

Entities:  

Mesh:

Year:  2007        PMID: 17623497     DOI: 10.1017/S0022215107009863

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Incidence and Clinical Outcomes of Streptococcus anginosus in Acute Complicated Sinusitis: A Pediatric Cohort.

Authors:  Elizabeth Troy; Stefan Sillau; Timothy J Bernard; Suchitra Rao
Journal:  J Pediatric Infect Dis Soc       Date:  2021-03-26       Impact factor: 3.164

2.  Milleri group streptococcus--a stepchild in the viridans family.

Authors:  Y Siegman-Igra; Y Azmon; D Schwartz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-06       Impact factor: 3.267

3.  Chronic Rhinosinusitis: MALDI-TOF Mass Spectrometry Microbiological Diagnosis and Electron Microscopy Analysis; Experience of the 2nd Otorhinolaryngology Clinic of Cluj-Napoca, Romania.

Authors:  Ionuț Isaia Jeican; Lucian Barbu Tudoran; Adrian Florea; Mirela Flonta; Veronica Trombitas; Anda Apostol; Mihai Dumitru; Maria Aluaș; Lia Monica Junie; Silviu Albu
Journal:  J Clin Med       Date:  2020-12-08       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.